Related references
Note: Only part of the references are listed.Antibody-mediated Targeting of the Urokinase-type Plasminogen Activator Proteolytic Function Neutralizes Fibrinolysis in Vivo
Ida K. Lund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Substrate-targeting γ-secretase modulators
Thomas L. Kukar et al.
NATURE (2008)
Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase
Lynette M. Kilpatrick et al.
BLOOD (2006)
Pro-urokinase-type plasminogen activator is a substrate for hepsin
Paul Moran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation
Mark A. Madsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A common allosteric site and mechanism in caspases
Justin M. Scheer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions
P Panizzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Unexpected effect of matrix metal loproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination
EI Deryugina et al.
CANCER RESEARCH (2005)
Discovery of an allosteric site in the caspases
JA Hardy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation
N Behrendt et al.
BIOCHEMICAL JOURNAL (2003)
Serine protease mechanism and specificity
L Hedstrom
CHEMICAL REVIEWS (2002)
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu et al.
CANCER CELL (2002)
Inhibitors of the protease domain of urokinase-type plasminogen activator
TW Rockway et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator - Relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme
HH Petersen et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism
R Egelund et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Peptide exosite inhibitors of factor VIIa as anticoagulants
MS Dennis et al.
NATURE (2000)
Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice
K List et al.
BIOCHEMISTRY (2000)
The plasminogen activation system in tumor growth, invasion, and metastasis
PA Andreasen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
Share Paper
